Serum and Urine Galectin-9, IP-10 and SIGLEC-1 as Biomarkers of Disease Activity in Patients with Systemic Lupus Erythematosus

被引：0

作者：

Mirioglu, Safak ^{[1
]}

Cinar, Suzan ^{[2
]}

Uludag, Omer ^{[3
]}

Gurel, Erdem ^{[3
]}

Varelci, Sibel ^{[3
]}

Ozluk, Yasemin ^{[4
]}

Kilicaslan, Isin ^{[4
]}

Yalcinkaya, Yasemin ^{[5
]}

Yazici, Halil ^{[6
]}

Gul, Ahmet ^{[3
]}

Inanc, Murat ^{[7
]}

Esen, Bahar ^{[5
]}

机构：

[1] Bezmialem Vakif Univ, Sch Med, Div Nephrol, Istanbul, Turkey

[2] Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Immunol, Istanbul, Turkey

[3] Istanbul Univ, Istanbul Sch Med, Div Rheumatol, Istanbul, Turkey

[4] Istanbul Univ, Istanbul Sch Med, Dept Pathol, Istanbul, Turkey

[5] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Rheumatol, Istanbul, Turkey

[6] Istanbul Univ, Istanbul Sch Med, Div Nephrol, Istanbul, Turkey

[7] Istanbul Univ, Fac Med, Istanbul, Turkey

来源：

ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0338

引用

页码：687 / 689

页数：3

共 50 条

[21] Downregulation of interferon inducible protein-10 (IP-10) by statins in patients with systemic lupus erythematosus (SLE) is associated with better control of disease activity
Law, W. G.
Kong, K. O.
Chng, H. H.
Lian, T. Y.
Leung, B. P. L.
Howe, H. S.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 474 - 475
[22] Serum Free Light Chains as Biomarkers for Systemic Lupus Erythematosus Disease Activity
Aggarwal, Rohit
Sequeira, Winston
Kokebie, Rediet
Mikolaitis, Rachel A.
Fogg, Lewis
Finnegan, Alison
Plaas, Anna
Block, Joel A.
Jolly, Meenakshi
ARTHRITIS CARE & RESEARCH, 2011, 63 (06) : 891 - 898
[23] CCL21 and IP10 as serum biomarkers for pulmonary involvement in systemic lupus erythematosus
Osman, Haidy M.
Omar, Gihan M.
Elameen, Nadia F.
Abdel-Nasser, Ahmed M.
LUPUS, 2022, 31 (06) : 706 - 715
[24] Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity
Thornhill, Susannah I.
Mak, Anselm
Lee, Bernett
Lee, Hui Yin
Poidinger, Michael
Connolly, John E.
Fairhurst, Anna-Marie
RHEUMATOLOGY, 2017, 56 (06) : 1025 - 1030
[25] Serum Albumin as a Marker for Disease Activity in Patients with Systemic Lupus Erythematosus
Yip, Jonathan
Aghdassi, Elaheh
Su, Jiandong
Lou, Wendy
Reich, Heather
Bargman, Joanne
Scholey, James
Gladman, Dafna D.
Urowitz, Murray B.
Fortin, Paul R.
JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1667 - 1672
[26] MCP-1 in urine as biomarker of disease activity in Systemic Lupus Erythematosus
Barbado, Julia
Martin, Debora
Vega, Luisa
Almansa, Raquel
Goncalves, Lisbeth
Nocito, Mercedes
Jimeno, Antonio
Ortiz de Lejarazu, Raul
Bermejo-Martin, Jesus F.
CYTOKINE, 2012, 60 (02) : 583 - 586
[27] ASSOCIATION OF SERUM AND URINE LEVELS OF TWEAK, MCP-1 AND NGAL WITH DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Mirioglu, Safak
Cinar, Suzan
Yazici, Halil
Gul, Ahmet
Ocal, Lale
Inanc, Murat
Artim-Esen, Bahar
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1166 - 1167
[28] Association of Serum and Urine Levels of TWEAK, MCP-1 and NGAL with Disease Activity in Systemic Lupus Erythematosus
Mirioglu, Safak
Cinar, Suzan
Yazici, Halil
Gul, Ahmet
Ocal, Lale
Inanc, Murat
Artim-Esen, Bahar
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[29] Serum Level of Syndecan-1 Is Associated with Disease Activity in Patients with Systemic Lupus Erythematosus
Baek, In-Woon
Kim, Ki-Jo
Kim, Ji-Young
Park, Su-Jung
Yoon, Chong-Hyeun
Kim, Wan-Uk
Cho, Chul Soo
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S266 - S266
[30] SERUM LEVEL OF SYNDECAN-1 IS ASSOCIATED WITH DISEASE ACTIVITY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Kim, K. -J.
Kim, J. -Y.
Park, S. -J.
Baek, I. -W.
Yoon, C. -H.
Kim, W. -U.
Cho, C. -S.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 216 - 217

← 1 2 3 4 5 →